In March 2025, the company declared new strategies for any direct-to-shopper featuring of its Wegovy weight loss drug. The company established a completely new pharmacy, referred to as NovoCare, which would cost shoppers $499 monthly for access to the drug, below 50 % the cost of the drug through other pharmaceutical distribution networks.[53]Other